双酚a辐照下头颈癌和胶质母细胞瘤细胞系生物学反应的比较。

IF 3.5 3区 生物学 Q1 BIOLOGY
Patricia Álvarez-Rodríguez, Cristina Méndez-Malagón, Maribel Porras-Quesada, María Pedrosa-Rivera, Ulli Köster, Ignacio Porras, Javier Praena, Rocío Estrada, Leonor Pérez-Fuentes, Juan Luis Osorio-Ceballos, Carmen Ruiz-Ruiz, Lucie Sancey, María José Ruiz-Magaña
{"title":"双酚a辐照下头颈癌和胶质母细胞瘤细胞系生物学反应的比较。","authors":"Patricia Álvarez-Rodríguez, Cristina Méndez-Malagón, Maribel Porras-Quesada, María Pedrosa-Rivera, Ulli Köster, Ignacio Porras, Javier Praena, Rocío Estrada, Leonor Pérez-Fuentes, Juan Luis Osorio-Ceballos, Carmen Ruiz-Ruiz, Lucie Sancey, María José Ruiz-Magaña","doi":"10.3390/biology14091252","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>In Boron Neutron Capture Therapy, treatment planning is based on a weighted dose in which dose components are weighted with different biological effectiveness (RBE) factors. The most important one for the tumor dose is the compound dependent biological effectiveness (CBE) factor which weighs the boron dose. This was established for brain tumors from radiobiological experiments and has been extrapolated to the more recent application of BNCT to head and neck cancers. The purpose of this work is to study the validity of this assumption.</p><p><strong>Methods: </strong>Two cell lines, CAL-33 (head and neck squamous cell carcinoma) and A172 (Glioblastoma Multiforme), were irradiated with a very pure thermal-equivalent neutron beam after BPA incubation, and the surviving fraction of cells after irradiation was determined by clonogenicity assays.</p><p><strong>Results: </strong>The Compound Biological Effectiveness of both cell lines is similar, although for head and neck carcinoma, 10% higher values are systematically found. In addition to this, radiobiological coefficients for the different dose components (photon, neutron and boron) of BNCT in both cell lines are provided.</p>","PeriodicalId":48624,"journal":{"name":"Biology-Basel","volume":"14 9","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467430/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparison of the Biological Response of a Head and Neck Carcinoma and a Glioblastoma Cell Line Under Neutron Irradiation with BPA Administration.\",\"authors\":\"Patricia Álvarez-Rodríguez, Cristina Méndez-Malagón, Maribel Porras-Quesada, María Pedrosa-Rivera, Ulli Köster, Ignacio Porras, Javier Praena, Rocío Estrada, Leonor Pérez-Fuentes, Juan Luis Osorio-Ceballos, Carmen Ruiz-Ruiz, Lucie Sancey, María José Ruiz-Magaña\",\"doi\":\"10.3390/biology14091252\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objective: </strong>In Boron Neutron Capture Therapy, treatment planning is based on a weighted dose in which dose components are weighted with different biological effectiveness (RBE) factors. The most important one for the tumor dose is the compound dependent biological effectiveness (CBE) factor which weighs the boron dose. This was established for brain tumors from radiobiological experiments and has been extrapolated to the more recent application of BNCT to head and neck cancers. The purpose of this work is to study the validity of this assumption.</p><p><strong>Methods: </strong>Two cell lines, CAL-33 (head and neck squamous cell carcinoma) and A172 (Glioblastoma Multiforme), were irradiated with a very pure thermal-equivalent neutron beam after BPA incubation, and the surviving fraction of cells after irradiation was determined by clonogenicity assays.</p><p><strong>Results: </strong>The Compound Biological Effectiveness of both cell lines is similar, although for head and neck carcinoma, 10% higher values are systematically found. In addition to this, radiobiological coefficients for the different dose components (photon, neutron and boron) of BNCT in both cell lines are provided.</p>\",\"PeriodicalId\":48624,\"journal\":{\"name\":\"Biology-Basel\",\"volume\":\"14 9\",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467430/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biology-Basel\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.3390/biology14091252\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biology-Basel","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3390/biology14091252","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的:在硼中子俘获治疗中,治疗计划是基于加权剂量,其中剂量成分与不同的生物有效性(RBE)因素加权。影响肿瘤剂量的最重要因素是复合依赖生物效应(CBE)因子,它决定了硼的剂量。这是从放射生物学实验中建立的脑肿瘤,并已推断到最近BNCT在头颈癌中的应用。这项工作的目的是研究这一假设的有效性。方法:将头颈部鳞状细胞癌CAL-33和多形性胶质母细胞瘤A172两株细胞系经双酚a孵育后用极纯热等效中子束照射,通过克隆原性实验测定照射后细胞的存活率。结果:两种细胞系的复合生物学效应相似,但在头颈部肿瘤中,系统地发现两种细胞系的复合生物学效应值高出10%。此外,还提供了两种细胞系中BNCT不同剂量组分(光子、中子和硼)的放射生物学系数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparison of the Biological Response of a Head and Neck Carcinoma and a Glioblastoma Cell Line Under Neutron Irradiation with BPA Administration.

Background and objective: In Boron Neutron Capture Therapy, treatment planning is based on a weighted dose in which dose components are weighted with different biological effectiveness (RBE) factors. The most important one for the tumor dose is the compound dependent biological effectiveness (CBE) factor which weighs the boron dose. This was established for brain tumors from radiobiological experiments and has been extrapolated to the more recent application of BNCT to head and neck cancers. The purpose of this work is to study the validity of this assumption.

Methods: Two cell lines, CAL-33 (head and neck squamous cell carcinoma) and A172 (Glioblastoma Multiforme), were irradiated with a very pure thermal-equivalent neutron beam after BPA incubation, and the surviving fraction of cells after irradiation was determined by clonogenicity assays.

Results: The Compound Biological Effectiveness of both cell lines is similar, although for head and neck carcinoma, 10% higher values are systematically found. In addition to this, radiobiological coefficients for the different dose components (photon, neutron and boron) of BNCT in both cell lines are provided.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Biology-Basel
Biology-Basel Biological Science-Biological Science
CiteScore
5.70
自引率
4.80%
发文量
1618
审稿时长
11 weeks
期刊介绍: Biology (ISSN 2079-7737) is an international, peer-reviewed, quick-refereeing open access journal of Biological Science published by MDPI online. It publishes reviews, research papers and communications in all areas of biology and at the interface of related disciplines. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. Electronic files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信